HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ancrod and fibrin formation: perspectives on mechanisms of action.

AbstractBACKGROUND AND PURPOSE:
Ancrod, derived from Malayan pit viper venom, has been tested as ischemic stroke treatment in clinical trials with inconsistent results. We studied the actions of ancrod on fibrinolysis pathways in patient plasma samples and endothelial cell culture systems.
METHODS:
We analyzed fibrinogen levels during the first 6 hours of ancrod infusion in patients entered in the Stroke Treatment with Ancrod Trial. For the in vitro study, human brain microvascular endothelial cells incubated with plasminogen or with human brain microvascular endothelial cell-conditioned medium were co-incubated with ancrod and fibrinogen under normal or oxygen-glucose deprivation conditions over 6 hours.
RESULTS:
Fibrinogen levels decreased both in vivo and in vitro. Ancrod generated fibrinopeptide A, caused visible clot formation, and reduced levels of tissue-type plasminogen activator antigen in the human brain microvascular endothelial cell system and in a cell-free system with conditioned media.
CONCLUSIONS:
The in vitro results indicate that ancrod causes local fibrin formation and secondary depletion of tissue-type plasminogen activator by binding to fibrin clot. Ancrod-induced fibrin formation could result in cerebral microvascular occlusion and may explain the suboptimal clinical effects of ancrod in human stroke trials.
AuthorsShuo Liu, Victor J Marder, David E Levy, Shur-Jen Wang, Fan Yang, Annlia Paganini-Hill, Mark J Fisher
JournalStroke (Stroke) Vol. 42 Issue 11 Pg. 3277-80 (Nov 2011) ISSN: 1524-4628 [Electronic] United States
PMID21868728 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media, Conditioned
  • Fibrin
  • Ancrod
Topics
  • Ancrod (therapeutic use)
  • Cells, Cultured
  • Culture Media, Conditioned
  • Endothelium, Vascular (drug effects, metabolism)
  • Fibrin (metabolism)
  • Humans
  • Stroke (blood, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: